![Ileen B. Winick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ileen B. Winick
Oficial de Recursos Humanos en
CANDEL THERAPEUTICS, INC.
.
Perfil
Ileen B. Winick currently works at Candel Therapeutics, Inc., as Chief People Officer from 2021.
Ms. Winick also formerly worked at Casebia Therapeutics LLC, as Senior Vice President-Human Resources.
Ms. Winick received her graduate degree from Cornell University and undergraduate degree from the University of Cincinnati (Ohio).
Cargos activos de Ileen B. Winick
| Empresas | Cargo | Inicio |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Oficial de Recursos Humanos | 01/01/2021 |
Antiguos cargos conocidos de Ileen B. Winick.
| Empresas | Cargo | Fin |
|---|---|---|
Casebia Therapeutics LLC
 Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Discovers, develops and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders, autoimmune disease | Oficial de Recursos Humanos | - |
Formación de Ileen B. Winick.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
3
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cincinnati (Ohio)
 University of Cincinnati (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Discovers, develops and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders, autoimmune disease | Health Technology |
- Bolsa de valores
- Insiders
- Ileen B. Winick
Elige MarketScreener 
